Possible available treatment option for early stage, small, node-negative, and HER2-overexpressing breast cancer
Kazuhiro Araki, Shigehira Saji, Michelle Gallas, Mark Pegram, Yasutsuna SasakiVolume:
19
Language:
english
Pages:
9
DOI:
10.1007/s12282-011-0296-z
Date:
April, 2012
File:
PDF, 224 KB
english, 2012